1-20 of 22
Douglas Hanahan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1652: Co-targeting distinct hallmark capabilities for therapeutic benefit in pre-clinical GBM models

Agnieszka Chryplewicz, Douglas Hanahan
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1652.
https://doi.org/10.1158/1538-7445.AM2021-1652
Published: 01 July 2021
View article titled, Abstract 1652: Co-targeting distinct hallmark capabilities for therapeutic benefit in pre-clinical GBM models
Journal Articles

Abstract 71: The immunocytokine PD1-IL2v overcomes immune checkpoint resistance, and combination with an anti-PD-L1 antibody further enhances its anti-tumor activity

Stephan Wullschleger, Mélanie Tichet, Laura Codarri-Deak, Pablo Umana, Christian Klein, Douglas Hanahan
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 71.
https://doi.org/10.1158/1538-7445.AM2021-71
Published: 01 July 2021
View article titled, Abstract 71: The immunocytokine PD1-IL2v overcomes immune checkpoint resistance, and combination with an anti-PD-L1 antibody further enhances its anti-tumor activity
Journal Articles

Abstract IA25: Hallmark capabilities modulated by the tumor microenvironment during tumor progression and adaptive resistance to therapy

Douglas Hanahan, Douglas Hanahan
Journal: Cancer Research
Cancer Res (2016) 76 (15_Supplement): IA25.
https://doi.org/10.1158/1538-7445.TME16-IA25
Published: 28 July 2016
View article titled, Abstract IA25: Hallmark capabilities modulated by the tumor microenvironment during tumor progression and adaptive resistance to therapy
Journal Articles

Abstract 1907: Multi-step microRNA control of pancreatic neuroendocrine tumors metastatic cascade

Iacovos P. Michael, Douglas Hanahan
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1907.
https://doi.org/10.1158/1538-7445.AM2016-1907
Published: 15 July 2016
View article titled, Abstract 1907: Multi-step microRNA control of pancreatic neuroendocrine tumors metastatic cascade
Journal Articles

Abstract LB-301: Copper chelation therapy suppresses tumor growth by inhibiting mitochondrial ATP production in tumors.

Seiko Ishida, Pénélope Andreux, Johan Auwerx, Douglas Hanahan
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): LB-301.
https://doi.org/10.1158/1538-7445.AM2013-LB-301
Published: 15 April 2013
View article titled, Abstract LB-301: Copper chelation therapy suppresses tumor growth by inhibiting mitochondrial ATP production in tumors.
Journal Articles

Abstract SY18-02: Molecular genetic subtypes of pancreas and colon cancer: Phenotypes and potential therapeutic significance.

Anguraj Sadanandam, Douglas Hanahan
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): SY18-02.
https://doi.org/10.1158/1538-7445.AM2013-SY18-02
Published: 15 April 2013
View article titled, Abstract SY18-02: Molecular genetic subtypes of pancreas and colon cancer: Phenotypes and potential therapeutic significance.
Journal Articles

Abstract 4391: CD20 as a target for therapy in solid tumors

Nesrine I. Affara, Brian Ruffell, Magnus Johansson, Kerri Fujikawa, Emily Bergsland, David G. DeNardo, Heather I. Chen, Nikhil Wadhwani, Martin Steinhoff, Morgan Truitt, Peter Olson, Douglas Hanahan, Yijin Li, Qian Gong, Yan Ma, Jane F. Wiesen, Grace Kim, Margaret Tempero, Frances Balkwill, Bryan Irving, Lisa M. Coussens
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4391.
https://doi.org/10.1158/1538-7445.AM2012-4391
Published: 15 April 2012
View article titled, Abstract 4391: CD20 as a target for therapy in solid tumors
Journal Articles

Abstract LB-403: Recurrent fusion transcripts in breast cancer

Anguraj Sadanandam, Stephan Wullschleger, Paul Spellman, Douglas Hanahan, Joe W. Gray
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): LB-403.
https://doi.org/10.1158/1538-7445.AM2012-LB-403
Published: 15 April 2012
View article titled, Abstract LB-403: Recurrent fusion transcripts in breast cancer
Journal Articles

Abstract LB-24: Molecular subtypes of pancreatic adenocarcinoma with different biological characteristics and therapeutical responses

Anguraj Sadanandam, Eric A. Collisson, Peter Olson, William J. Gibb, Morgan Truitt, Adam Olshen, Margaret A. Tempero, Paul T. Spellman, Douglas Hanahan, Joe W. Gray
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): LB-24.
https://doi.org/10.1158/1538-7445.AM2011-LB-24
Published: 15 April 2011
View article titled, Abstract LB-24: Molecular subtypes of pancreatic adenocarcinoma with different biological characteristics and therapeutical responses
Journal Articles

Abstract 752: A CCR4 antagonist combined with protein-or DNA-based vaccines efficiently breaks tolerance and elicits CD8+T cells directed against self and viral associated tumor antigens

Helene Pere, Yves Montier, Jagadeesh Bayry, Françoise Quintin-Colonna, Nathalie Merillon, Patrice Ravel, Cecile Badoual, Alain Gey, Federico Sandoval, Luis C. Ferreira, Douglas Hanahan, Herve Fridman, Brad H. Nelson, Ludger Johannes, Eric Tartour
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 752.
https://doi.org/10.1158/1538-7445.AM2011-752
Published: 15 April 2011
View article titled, Abstract 752: A CCR4 antagonist combined with protein-or DNA-based vaccines efficiently breaks tolerance and elicits CD8+T cells directed against self and viral associated tumor antigens
Journal Articles

Inhibition of Cysteine Cathepsin Protease Activity Enhances Chemotherapy Regimens by Decreasing Tumor Growth and Invasiveness in a Mouse Model of Multistage Cancer

Katherine M. Bell-McGuinn, Alfred L. Garfall, Matthew Bogyo, Douglas Hanahan, Johanna A. Joyce
Journal: Cancer Research
Cancer Res (2007) 67 (15): 7378–7385.
https://doi.org/10.1158/0008-5472.CAN-07-0602
Published: 01 August 2007
View article titled, Inhibition of Cysteine Cathepsin Protease Activity Enhances Chemotherapy Regimens by Decreasing Tumor Growth and Invasiveness in a Mouse Model of Multistage Cancer
Open the PDF for Inhibition of Cysteine Cathepsin Protease Activity Enhances Chemotherapy Regimens by Decreasing Tumor Growth and Invasiveness in a Mouse Model of Multistage Cancer in another window
Journal Articles

Lymphatic Zip Codes in Premalignant Lesions and Tumors

Lianglin Zhang, Enrico Giraudo, Jason A. Hoffman, Douglas Hanahan, Erkki Ruoslahti
Journal: Cancer Research
Cancer Res (2006) 66 (11): 5696–5706.
https://doi.org/10.1158/0008-5472.CAN-05-3876
Published: 01 June 2006
View article titled, Lymphatic Zip Codes in Premalignant Lesions and Tumors
Open the PDF for Lymphatic Zip Codes in Premalignant Lesions and Tumors in another window
Includes: Supplementary data
Journal Articles

Cysteine cathepsin inhibition in combination with a maximum-tolerated dose and metronomic dose “chemo-switch” regimen leads to tumor regression and an overall survival benefit in a murine model of cancer

Katherine M. Bell-Mcguinn, Matthew Bogyo, Douglas Hanahan, Johanna Joyce
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 573–574.
Published: 15 April 2006
View article titled, Cysteine cathepsin inhibition in combination with a maximum-tolerated dose and metronomic dose “chemo-switch” regimen leads to tumor regression and an overall survival benefit in a murine model of cancer
Journal Articles

CD4+ T Cell-Mediated Antigen-Specific Immunotherapy in a Mouse Model of Cervical Cancer

Dylan Daniel, Christopher Chiu, Enrico Giraudo, Masahiro Inoue, Lee A. Mizzen, N. Randall Chu, Douglas Hanahan
Journal: Cancer Research
Cancer Res (2005) 65 (5): 2018–2025.
https://doi.org/10.1158/0008-5472.CAN-04-3444
Published: 07 March 2005
View article titled, CD4<sup>+</sup> T Cell-Mediated Antigen-Specific Immunotherapy in a Mouse Model of Cervical Cancer
Open the PDF for CD4<sup>+</sup> T Cell-Mediated Antigen-Specific Immunotherapy in a Mouse Model of Cervical Cancer in another window
Journal Articles

Oncogene Expression and Genetic Background Influence the Frequency of DNA Copy Number Abnormalities in Mouse Pancreatic Islet Cell Carcinomas

Jeffrey H. Hager, J. Graeme Hodgson, Jane Fridlyand, Sujatmi Hariono, Joe W. Gray, Douglas Hanahan
Journal: Cancer Research
Cancer Res (2004) 64 (7): 2406–2410.
https://doi.org/10.1158/0008-5472.CAN-03-3522
Published: 01 April 2004
View article titled, Oncogene Expression and Genetic Background Influence the Frequency of DNA Copy Number Abnormalities in Mouse Pancreatic Islet Cell Carcinomas
Open the PDF for Oncogene Expression and Genetic Background Influence the Frequency of DNA Copy Number Abnormalities in Mouse Pancreatic Islet Cell Carcinomas in another window
Includes: Supplementary data
Journal Articles

Fourteenth Annual Pezcoller Symposium: The Novel Dichotomy of Immune Interactions with Tumors

Douglas Hanahan, Antonio Lanzavecchia, Enrico Mihich
Journal: Cancer Research
Cancer Res (2003) 63 (11): 3005–3008.
Published: 01 June 2003
View article titled, Fourteenth Annual Pezcoller Symposium: <subtitle>The Novel Dichotomy of Immune Interactions with Tumors</subtitle>
Open the PDF for Fourteenth Annual Pezcoller Symposium: <subtitle>The Novel Dichotomy of Immune Interactions with Tumors</subtitle> in another window
Journal Articles

Antitumor Effects in Mice of Low-dose (Metronomic) Cyclophosphamide Administered Continuously through the Drinking Water

Shan Man, Guido Bocci, Giulio Francia, Shane K. Green, Serge Jothy, Douglas Hanahan, Peter Bohlen, Daniel J. Hicklin, Gabriele Bergers, Robert S. Kerbel
Journal: Cancer Research
Cancer Res (2002) 62 (10): 2731–2735.
Published: 01 May 2002
View article titled, Antitumor Effects in Mice of Low-dose (Metronomic) Cyclophosphamide Administered Continuously through the Drinking Water
Open the PDF for Antitumor Effects in Mice of Low-dose (Metronomic) Cyclophosphamide Administered Continuously through the Drinking Water in another window
Journal Articles

Tumor-derived Expression of Vascular Endothelial Growth Factor Is a Critical Factor in Tumor Expansion and Vascular Function

Jeremy Grunstein, W. Gregory Roberts, Odile Mathieu-Costello, Douglas Hanahan, Randall S. Johnson
Journal: Cancer Research
Cancer Res (1999) 59 (7): 1592–1598.
Published: 01 April 1999
View article titled, Tumor-derived Expression of Vascular Endothelial Growth Factor Is a Critical Factor in Tumor Expansion and Vascular Function
Open the PDF for Tumor-derived Expression of Vascular Endothelial Growth Factor Is a Critical Factor in Tumor Expansion and Vascular Function in another window
Journal Articles

Tumor Microenvironment Can Restrict the Effectiveness of Activated Antitumor Lymphocytes

Ruth Ganss, Douglas Hanahan
Journal: Cancer Research
Cancer Res (1998) 58 (20): 4673–4681.
Published: 01 October 1998
View article titled, Tumor Microenvironment Can Restrict the Effectiveness of Activated Antitumor Lymphocytes
Open the PDF for Tumor Microenvironment Can Restrict the Effectiveness of Activated Antitumor Lymphocytes in another window
Journal Articles

Up-Regulation of Vascular Endothelial Growth Factor Expression in a Rat Glioma Is Conferred by Two Distinct Hypoxia-driven Mechanisms

Annette Damert, Marcia Machein, Georg Breier, Masaki Q. Fujita, Douglas Hanahan, Werner Risau, Karl H. Plate
Journal: Cancer Research
Cancer Res (1997) 57 (17): 3860–3864.
Published: 01 September 1997
View article titled, Up-Regulation of Vascular Endothelial Growth Factor Expression in a Rat Glioma Is Conferred by Two Distinct Hypoxia-driven Mechanisms
Open the PDF for Up-Regulation of Vascular Endothelial Growth Factor Expression in a Rat Glioma Is Conferred by Two Distinct Hypoxia-driven Mechanisms in another window